End Drug Shortages Act

The End Drug Shortages Act amends federal law to address drug shortages by expanding the definition to include unexpected surges in demand, not just production interruptions. It requires drug manufacturers to notify the FDA at least six months in advance of planned production stops or as soon as possible for surges in demand, with clearer reporting about shortage duration. This affects manufacturers, healthcare providers, and patients by improving transparency about supply issues and enabling earlier planning. The bill also updates compounding facility rules to align with current practices, aiming to strengthen the drug supply chain.